SEC Form 4 · accession 0001193125-26-267800
TREACE MEDICAL CONCEPTS, INC. · TMCI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
John T. Treace
Officer — Chief Executive Officer · Director · 10% Owner
Period of report
Jun 10, 2026
Accepted (ET)
Jun 11, 2026 · 4:52 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001630627
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Jun 10, 2026 | P | 29,430 | $4.024 | A | 7,353,263 | D | |
| Common StockF3,F2 | Jun 11, 2026 | P | 22,887 | $4.0434 | A | 7,376,150 | D | |
| Common StockF4 | holding | — | — | — | 1,605,000 | I | By spouse | |
| Common StockF4 | holding | — | — | — | 1,471,250 | I | By spouse as trustee of a trust | |
| Common StockF5 | holding | — | — | — | 1,839,063 | I | As trustee of a trust | |
| Common StockF5 | holding | — | — | — | 408,816 | I | As co-trustee of a trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $3.9300 to $4.1000 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.
- F2Includes 542,784 restricted stock units.
- F3The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $3.9600 to $4.1700 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.
- F4The Reporting Person disclaims beneficial ownership of shares held by his wife directly or in trusts for which his wife serves as trustee or co-trustee.
- F5The Reporting Person disclaims beneficial ownership of shares held in trust for which he serves as trustee or co-trustee.